MedClair International AB agreed to acquire Spintso International AB (publ) (NGM:SPIN) in a reverse merger transaction for SEK 20 million on August 18, 2020. As part of the consideration, Spintso International will pay SEK 40 million by issuing 50 million shares to MedClair International. Post the acquisition, MedClair International will hold 83% stake and the existing shareholders of Spintso International will hold 17% stake in Spintso International. Fredrik Crafoord will be the chairman of Spintso International.